Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin

S M Newton1, M Kotb, T P Poirier

  • 1Department of Microbiology and Immunology, Stanford University School of Medicine, California 94305.

Insights

This study engineered a Salmonella vaccine to express a Streptococcus pyogenes M protein epitope on its flagella. This chimeric vaccine successfully elicited protective immunity against type 5 Streptococcus pyogenes in mice.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccine Development

Background:

  • Streptococcus pyogenes M protein is crucial for virulence and a target for protective immunity.
  • Developing effective vaccines against Streptococcus pyogenes remains a challenge.
  • Heterologous protein expression in bacterial flagella offers a novel vaccine delivery strategy.

Purpose of the Study:

  • To engineer a live Salmonella vaccine expressing a Streptococcus pyogenes M protein epitope.
  • To evaluate the immunogenicity and protective efficacy of the engineered vaccine.

Main Methods:

  • A synthetic oligonucleotide encoding the M protein epitope was inserted into the Salmonella flagellin gene.
  • The modified Salmonella strain was used to immunize mice.
  • Immunogenicity was assessed by antibody titers and opsonization assays.
  • Protective efficacy was determined by challenge experiments with Streptococcus pyogenes.

Main Results:

  • The engineered Salmonella vaccine successfully expressed the M protein epitope on its flagella.
  • Immunization induced high titers of M protein-specific antibodies and opsonizing antibodies.
  • Mice immunized with the engineered vaccine showed significant protection against Streptococcus pyogenes type 5 challenge.

Conclusions:

  • An M protein epitope can be expressed in an unrelated protein (flagellin) while retaining immunogenicity.
  • A live Salmonella vaccine displaying a Streptococcus pyogenes M protein epitope can confer protection against infection.
  • This approach represents a promising strategy for developing novel vaccines against bacterial pathogens.